Capsugel Switzerland AG
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Nov 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 30, 2026The maintenance fee for Carnitine Granulate and Methods for Its Production (US 9,066,868) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
- 1 fee due Jan 21, 2027The maintenance fee for Spray-Drying Process for Producing a Dry Caritine Powder or Granulate (US 9,084,431) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Jul 5, 2027The maintenance fee for Process for the Production of 4-Chloroacetoacetyl Chloride, 4-Chloroacetoacetic Acid Esters, Amides and Imides (US 9,227,905) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,084,431 | Spray-Drying Process for Producing a Dry Caritine Powder or Granulate In force · High confidence | In force | High confidence | |
| US 8,168,823 | Process for the Preparation of Betaines In force · High confidence | In force | High confidence | |
| US 8,604,237 | Methods for the Production of L-Carnitine In force · High confidence | In force | High confidence | |
| US 9,066,868 | Carnitine Granulate and Methods for Its Production In force · High confidence | In force | High confidence | |
| US 8,614,343 | Process for the Production of a Fatty Acid/Carnitine Derivative In force · High confidence | In force | High confidence | |
| US 8,784,844 | Arabinogalactan for Enhancing the Adaptive Immune Response In force · High confidence | In force | High confidence | |
| US 8,431,741 | Process for the Hydrogenation of Ketoesters In force · High confidence | In force | High confidence | |
| US 8,470,382 | Carnitine Granulate and Methods for Its Production In force · High confidence | In force | High confidence | |
| US 10,130,602 | Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function In force · High confidence | In force | High confidence | |
| US 8,779,188 | Process for the Production of L-Carnitine Tartrate In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.